Factors affecting the quality of life after ischemic stroke in young adults: a scoping review
Health and Quality of Life Outcomes · 19.01.2023 · 21 (1)
DOI: 10.1186/s12955-023-02090-5 ↗Kurz gefasst
Scoping Review in der Zeitschrift Health and Quality of Life Outcomes, online erschienen am 19.01.2023. Verfasst von Elena Gurková und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Faculty of Health Sciences, Palacký University Olomouc, Hněvotínská 976/3, 775 15, Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Health of the Czech Republic, The Internal Grant Agency of Palacký University Olomouc.
Themen: Schlaganfall
Abstract (Originalsprache)
Purpose
To synthesize the body of knowledge on the factors influencing the quality of life (QoL) after ischemic stroke (IS) in young adults.
Methods
Guidelines regarding the scoping review methodology developed by the Joanna Briggs Institute, and the PRISMA-ScR checklist for a scoping review was used in this paper. A total of 1197 studies were identified through a bibliographic search in Web of Science, MEDLINE, PsycInfo, ScienceDirect, Scopus, and ProQuest Science Database. Articles published between the years 2000–2021 were included.
Results
A total of nine papers were finally selected to respond to the research question. Three studies were prospective longitudinal studies compared QoL between young stroke and age-matched controls from the general population. Across all the analysed studies, 14 variables potentially associated with QoL were identified. QoL in young patients is mainly affected by clinical outcomes after IS (scored by the modified Rankin scale and the Barthel index—favourable initial functional status and higher independence in ADL leads to higher QoL) and psychological factors (post-stroke fatigue and depression—higher levels of fatigue and depression lead to lower QoL). The reviewed studies emphasized the importance of functional outcomes, post-stroke depression, fatigue and anxiety and early return to work.
Conclusion
Further longitudinal studies are needed to identify the trajectory of post-stroke psychosocial symptoms over time and other potential predictors of unfavourable long-term QoL, thus specific young stroke rehabilitation and stroke self-management support programmes should be developed (address physical, psychological factors which influence the psychosocial adaptation post-stroke and the perception of the QoL).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Faculty of Health Sciences, Palacký University Olomouc, Hněvotínská 976/3, 775 15, Olomouc, Czech Republic.
- Department of Nursing, Faculty of Health Sciences, Palacký University Olomouc, Hněvotínská 976/3, 775 15, Olomouc, Czech Republic. lenka.sturekova@upol.cz.
- Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic.
Förderung
- The Ministry of Health of the Czech Republic
- The Internal Grant Agency of Palacký University Olomouc
Zitieren
APA
Gurková, E., Štureková, L., Mandysová, P., & Šaňák, D. (2023). Factors affecting the quality of life after ischemic stroke in young adults: a scoping review. Health and Quality of Life Outcomes, 21(1). https://doi.org/10.1186/s12955-023-02090-5
Vancouver
Gurková E, Štureková L, Mandysová P, Šaňák D. Factors affecting the quality of life after ischemic stroke in young adults: a scoping review. Health and Quality of Life Outcomes. 2023;21(1). doi:10.1186/s12955-023-02090-5
BibTeX
@article{Gurkov2023,
author = {Gurková, Elena and Štureková, Lenka and Mandysová, Petra and Šaňák, Daniel},
title = {Factors affecting the quality of life after ischemic stroke in young adults: a scoping review},
journal = {Health and Quality of Life Outcomes},
year = {2023},
volume = {21},
number = {1},
doi = {10.1186/s12955-023-02090-5}
}
EUVIMED